Cost-effectiveness of maintenance rituximab treatment after second line therapy in patients with follicular non-Hodgkin's lymphoma in Sweden

被引：0
|
作者：
Kasteng, F. [1 ]
Erlanson, M. [2 ]
Hagberg, H. [3 ]
Kimby, E. [4 ]
Relander, T. [5 ]
Lunckvist, J. [1 ]
机构：
[1] i3 Innovus, Stockholm, Sweden
[2] Univ Umea Hosp, S-90185 Umea, Sweden
[3] Univ Uppsala Hosp, Uppsala, Sweden
[4] Karolinska Univ Hosp, Stockholm, Sweden
[5] Univ Lund Hosp, S-22185 Lund, Sweden
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65187-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A331 / A331
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of maintenance rituximab treatment after second line therapy in patients with follicular lymphoma in Sweden
    Kasteng, Frida
    Erlanson, Martin
    Hagberg, Hans
    Kimby, Eva
    Relander, Thomas
    Lundkvist, Jonas
    ACTA ONCOLOGICA, 2008, 47 (06) : 1029 - 1036
  • [2] Cost-Effectiveness of Rituximab for Maintenance in Patients with Follicular Non-Hodgkin's Lymphoma in the Dutch Setting
    Pompen, Marjolein
    Huijgens, P. C.
    BLOOD, 2008, 112 (11) : 824 - 824
  • [3] Cost-effectiveness of rituximab as maintenance therapy in patients with follicular non-Hodgkin lymphoma after responding to first-line rituximab plus chemotherapy
    Hornberger, John
    Chien, Rebecca
    Friedmann, Mark
    Han, Leona
    Shewade, Ashwini
    Satram-Hoang, Sacha
    Reyes, Carolina
    LEUKEMIA & LYMPHOMA, 2012, 53 (12) : 2371 - 2377
  • [4] An Evaluation of the Cost-Effectiveness of Rituximab in Combination with Chemotherapy for the First-Line Treatment of Follicular Non-Hodgkin's Lymphoma in the UK
    Ray, Joshua A.
    Carr, Emma
    Lewis, Gavin
    Marcus, Robert
    VALUE IN HEALTH, 2010, 13 (04) : 346 - 357
  • [5] Cost-effectiveness of rituximab maintenance therapy for patients with follicular lymphoma: The Spanish perspective
    Gomez Codina, J.
    Provencio, M.
    Rueda, A.
    Capote, F.
    Carbonell, F.
    Conde, E.
    Fernandez Ranada, J.
    Giraldo, P.
    Rios, E.
    Varela, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] COST-EFFECTIVENESS ANALYSIS OF MAINTENANCE TREATMENT WITH RITUXIMAB IN PATIENTS WITH FOLLICULAR LYMPHOMA RESPONDING TO FIRST LINE INDUCTION THERAPY IN PORTUGAL
    Pereira, C.
    Rubio Terres, C.
    Rubio Rodriguez, D.
    VALUE IN HEALTH, 2014, 17 (07) : A530 - A531
  • [7] SEQUENTIAL TREATMENT OF FOLLICULAR NON-HODGKIN LYMPHOMA: COST-EFFECTIVENESS AND VALUE OF INFORMATION
    Soini, E. J.
    Martikainen, J. A.
    Vihervaara, V.
    Mustonen, K.
    Nousiainen, T.
    VALUE IN HEALTH, 2011, 14 (07) : A239 - A240
  • [8] Cost-Effectiveness Analysis of Maintenance Therapy with Rituximab in Patients with Follicular Lymphoma Responding to Induction Therapy at the First Line
    Castro Gomez, Antonio J.
    Lopez-Guillermo, Armando
    Rueda Dominguez, Antonio
    Salar, Antonio
    Varela Moreno, Cristina
    Rubio-Terres, Carlos
    REVISTA ESPANOLA DE SALUD PUBLICA, 2012, 86 (02): : 163 - 176
  • [9] THE COST EFFECTIVENESS OF RITUXIMAB MAINTENANCE THERAPY IN PATIENTS WITH FOLLICULAR LYMPHOMA
    Mervin, M. C.
    VALUE IN HEALTH, 2016, 19 (03) : A153 - A153
  • [10] Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma
    Hainsworth, JD
    Litchy, S
    Burris, HA
    Scullin, DC
    Corso, SW
    Yardley, DA
    Morrissey, L
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (20) : 4261 - 4267
12345